| Similar Articles |
|---|
 |
Pharmaceutical Executive
December 1, 2010
Andrea LaFountain |
Adherence Equation: The Code is Cracked! Putting science front-and-center in the design of patient adherence programs can lead to a better understanding of the commitment required to get patients to take their medicine   |
Pharmaceutical Executive
March 1, 2011
Andrea LaFountain |
Where have all the Scientists Gone? With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence. |
Pharmaceutical Executive
May 1, 2009
Jay Bigelow |
Behavior and the Bottom Line In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing. |
Pharmaceutical Executive
December 1, 2011
William Looney |
The Medicines Adherence Challenge Keeping skittish patients on their medicines ought to be a strategic priority for Big Pharma, but is it? An expert round table examines how best to make progress and agree on some practical steps for incorporation in the campaign agenda. |
Pharmaceutical Executive
July 1, 2009
Patrick Clinton |
What to Buy In the long run, pharma wants to sell health, not just drugs. |
CRM
September 1, 2006
David Myron |
Downtime Is Dead When consumers' days are filled with all work and no play, it makes communicating with them even more difficult than usual. |
On Wall Street
August 1, 2011
Denise Federer |
Guiding Choices to Secure A Client's Future As an advisor you have the potential to play a powerful role in guiding your clients to make tough choices and initiate steps that ensure their family's financial futures. |
Pharmaceutical Executive
August 1, 2011
Jennifer Ringler |
The Adherence Fight: A TKO? Why does the match against medicines compliance always seem to end in an easy knockout? |
Pharmaceutical Executive
October 1, 2008
Patrick Clinton |
Future Shock A vision of pharma's next business model is starting to emerge. But how do we get from here to there? |
Pharmaceutical Executive
May 1, 2012
William Looney |
Seeding Beyond the Base The pharmaceutical industry's reputation as a growth industry no one wants to pay for is more secure than ever. |
Pharmaceutical Executive
June 1, 2013
William Looney |
Recognizing the Best Getting patients to take their medicine on spec and on time is the challenge that never goes away; it's the deadweight baggage accompanying every industry innovation since the arrival of aspirin a century ago. |
Pharmaceutical Executive
July 1, 2013
William Looney |
Talent, Terror, and the Turnaround We offer news on 15 new Emerging Pharma Leaders, business innovation, and terrorism threats to the pharmaceutical industry. |
Pharmaceutical Executive
January 1, 2012
William Looney |
Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap. |
